论文部分内容阅读
AIM To consolidate the present evidence of effectiveness in renal functioning and graft survival following early introduction of mammalian target of rapamycin(mTOR)inhibitors with or without calcineurin inhibitors(CNIs)in renal transplant recipients.METHO